celecoxib has been researched along with 15-hydroxy-5,8,11,13-eicosatetraenoic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dennis, EA; Glass, CK; Gosselin, D; Norris, PC; Reichart, D | 1 |
Anderson, AJ; Dong, L; Malkowski, MG | 1 |
2 other study(ies) available for celecoxib and 15-hydroxy-5,8,11,13-eicosatetraenoic acid
Article | Year |
---|---|
Phospholipase A2 regulates eicosanoid class switching during inflammasome activation.
Topics: Animals; Aspirin; Celecoxib; Cell Line, Transformed; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Eicosanoids; Group IV Phospholipases A2; Hydroxyeicosatetraenoic Acids; Inflammasomes; Interleukin-1; Lipidoses; Macrophages; Male; Mice; Mice, Inbred C57BL; Pyrazoles; Receptors, Purinergic P2X7; Signal Transduction; Sulfonamides; Toll-Like Receptor 4 | 2014 |
Arg-513 and Leu-531 Are Key Residues Governing Time-Dependent Inhibition of Cyclooxygenase-2 by Aspirin and Celebrex.
Topics: Animals; Arachidonic Acid; Arginine; Aspirin; Celecoxib; Crystallography, X-Ray; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Enzyme Assays; Histidine; Hydroxyeicosatetraenoic Acids; Leucine; Mutagenesis, Site-Directed; Recombinant Proteins; Sf9 Cells; Stereoisomerism; Substrate Specificity; Time Factors | 2019 |